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doi:10.1016/j.kjms.2012.04.007Abstract Degenerative cervical spondylosis (DCS) is part of the aging process and is the most
common reason for degenerative changes with the spinal column. Anterior cervical discectomy
and fusion (ACDF) is a major option for operative management of DCS in our institution. This
retrospective study investigated the frequency of postoperative complications and resource
utilization in 145 patients who underwent ACDF procedures from January 2009 to December
2011. Patients with degenerative changes that involved cervical intervertebral levels C1eC2,
spinal injury of traumatic origin, spinal tumors, or previous cervical fusion were excluded.
Patients were then further classified into two groups: (1) level 1 or 2 disease (Group M) and
(2) level 3 or 4 disease (Group S). Measures of mortality, complications after surgery as well
as immediate reoperation for any reason were evaluated. Operation time, length of hospital
stay, and hospitalization cost were defined as resource utilization. Ninety seven patients
met the inclusion criteria and were further reviewed to characterize the sample better. There
were no hematomas, airway complications or deaths, except in one patient who developed
postoperative hemorrhage that required immediate surgical intervention, and resolved
without any neurological deficit or casualty. Resource utilization indicated that the average
operation time for Group S was significantly higher than for Group M (4.31  1.25 vs.
2.88 0.90 hours, p< 0.0001). There were no significant differences in length of hospital stay
and hospitalization cost between the two groups (pZ 0.265 and pZ 0.649). Our results indi-
cate that neurosurgical intervention is safe for patients with DSC. Postoperative complication
rates associated with these procedures are low. When surgery is considered appropriate for
patients with multilevel diseases, these data suggest that ACDF is a safe surgical option.
Copyright ª 2012, Elsevier Taiwan LLC. All rights reserved.stitute of Healthcare Administration, Kaohsiung Medical University, No. 100, Shi-Quan 1st Road, San-
n.
(K.-T. Lee).
vier Taiwan LLC. All rights reserved.
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the study (KMUH-IRB-990271). Based on InternationalAnterior discectomy with or without fusion is the most
common surgical intervention performed for degenerative
cervical spondylosis (DCS), with established literature of its
efficacy and natural history [1,2]. When surgery is indicated,
the choice of operative approaches including anterior,
posterior, and combined procedures becomes a significant
part in the optimal management of the disease. Hospital
pressure for lower hospitalization cost because of the limited
resources offered by national health insurance has always
pushed surgeons to come up with innovative ideas to perform
surgery. DCS refers to age-related disc degeneration and the
population profile in Taiwan is aging, therefore, it is
predictable that the resource utilization of patients with DCS
will increase with time.
In this study, we report the incidence of postoperative
complications and resource utilization for 97 patients
undergoing anterior cervical discectomy and fusion (ACDF)
for multilevel disease from January 2009 to December
2010. The aim of the study was to investigate factors
related to complications, operation time, the associated
length of hospital stay, and hospitalization cost.
Patients and methods
All patients undergoing ACDF in the Section of Neurosur-
gery in our institution between January 2009 and
December 2010 were enrolled in the study, and data
were collected prospectively and then reviewedFigure 1. Patient selection flow diagram demonstrating identifica
fusion for degenerative cervical spondylosis in Kaohsiung Medical
722.0Z displacement of cervical intervertebral disc without myelo
cervical region; 722.91Z other and unspecified disc disorder, cervi
of the anterior column, anterior technique. ICD9Z International Cretrospectively. The Institutional Review Board approved
Classification of Diseases, Ninth Revision, Clinical Modifi-
cation (ICD-9-CM), all patients included were diagnosed
with DCS (diagnosis code: 722.0, 722.71, or 722.91) and
scheduled for ACDF (procedure code: 81.02). Patients
were excluded based on C1eC2 involvement, trauma,
neoplasia, or previous cervical fusion, and then further
classified into two groups: (1) level 1 or 2 disease (Group
M; patients with clinically mild diseases who might use
fewer medical resources); and (2) level 3 or 4 disease
(Group S; patients with clinically severe diseases who
were supposed to use more medical resources). Cervical
degenerative disease levels were defined according to the
number of intervertebral discs involved, that is, level 1 or
2 disease indicated pathology of two or three discs, and
level 3 or 4 disease involved four or five discs. At present
there are no definitive guidelines within the literature as
to what delineates the patient population that can be
safely and economically managed through ACDF. However,
patients with either stenosis or herniated nucleus pulpo-
sus involving level 1 or 2 disease are increasingly managed
on an outpatient basis [3,4]. In addition, clinical results
after level 3 or 4 ACDF are seldom reported in the liter-
ature [5].
Information regarding age, sex, medical comorbidity,
history of smoking, body mass index (BMI), and surgical
details was collected, and routine blood workup, including
blood cell count, prothrombin and partial thromboplastin
times, and international normalized ratio, were routinely
obtained. ICD-9 diagnosis codes were used to generatetion of population sample for anterior cervical discectomy and
University Hospital from 2009 to 2010. ICD-9 diagnostic code:
pathy; 722.71Z intervertebral disc disorder with myelopathy,
cal region. ICD-9 procedure code: 81.02Z other cervical fusion
lassification of Diseases, Ninth Revision.
Table 1 Demographic data of the population sample
(nZ 97).
n/mean SD %/range
Sex
Female 54 55.7
Male 43 44.3
CCI
 1 50 51.5
0 47 48.5
Age (yr) 55.44 12.99 22e85
BMI 24.32 3.96 17.58e38.72
Single-level 16 16.5
C3eC4 1
C4eC5 2
C5eC6 11
C6eC7 2
Two-level 30 30.9
C3eC5 4
C4eC6 17
C5eC7 7
C3eC4, C6eC7 1
C4e5, C6eC7 1
Three-level 29 29.9
C3eC6 14
C4eC7 11
Others 4
Four-level 22 22.7
C3eC7 19
C4eC7eT1 3
Fusion material
PEEK cage 67 69.0
Bryan disc 15 15.5
Both 15 15.5
BMIZ body mass index; CCIZ Charlson Comorbidity Index;
PEEKZ polyetheretherketone; SDZ standard deviation.
Table 2 Demographic information of the study groups
(nZ 97).
Group M
(nZ 46)
Group S
(nZ 51)
p value
Age (yr) 51.75 13.63 58.77 11.53 0.007
BMI 24.03 3.98 24.58 3.96 0.500
Sex (n; %)
Female 28 (60.9) 26 (51.0) 0.414
Male 18 (39.1) 25 (49.0)
CCI (%)
 1 21 (45.7) 29 (56.9) 0.312
0 25 (54.3) 22 (43.1)
Fusion material 0.001
PEEK cage 32 35
Bryan disc 12 3
Both 2 13
Student t test was used to derive p value for age and BMI,
Fisher’s exact test for gender and CCI, and c2 test for fusion
material. BMIZ body mass index; CCIZ Charlson Comorbidity
Index; PEEKZ polyetheretherketone.
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variables) for each patient. Outcome variables contained
postoperative complications, mortality, and resource
utilization, which included operation time, length of
hospital stay, and hospitalization cost. Cost data were
estimated by using hospital inpatient reimbursement
(National Health Insurance) data. Statistical analyses for
the study were performed using SPSS for Windows version
12.0. Student t tests and Fisher’s exact tests were used to
compare the results of the study. Log-linear regression
model was used to identify factors affecting resource
utilization.Results
A total of 97 patients underwent elective level 1e4 ACDF
procedures during the study period (Fig. 1); 16 patients
(16.5%) underwent a single-level procedure; 30 patients
(30.9%) a two-level procedure; 29 patients (29.9%)
a three-level procedure; and 22 patients (22.7%) a four-
level procedure (Table 1). Fifty-four patients (55.7%)
were female. Average age of the population sample was
55.44 years (range: 22e85 years) with a standard devia-
tion of 12.99. When analyzing pre-existing medical
conditions, 51.5% of patients had at least a chronic
disease before surgery. All patients were instrumented,
and prosthesis was used. As fusion material, a poly-
etheretherketone cage was used for 67 patients (69.0%),
Bryan disc was provided to 15 patients (15.5%), and both
polyetheretherketone cage and Bryan disc were offered
simultaneously to 15 patients (15.5%). The demographic
information about age, BMI, sex, clinical status, and the
prosthesis used for the study groups is described in
Table 2. There were 46 patients in Group M and 51 in
Group S. However, the two study groups had no substan-
tive differences in any variables apart from age. Patients
in Group S were significantly older. The type of prosthesis
used was significantly related to disease severity.
There was one complication (1.0%) involving post-
operative hemorrhage, which required immediate surgical
intervention and was resolved without any neurological
deficit or casualty. The patient was originally diagnosed
with herniated intervertebral discs with stenosis at the
C3eC4, C5eC6 and C6eC7 levels. There were no hema-
tomas, airway complications or deaths.
The preliminary results of analysis of resource utiliza-
tion are shown in Table 3, which demonstrated that the
operation time for the population sample ranged from
1.33 to 7.67 hours (mean: 3.62 hours). The operation time
for patients in Group S was significantly higher longer than
for Group M (4.31 1.25 vs. 2.88 0.90 hours,
p< 0.0001). The average length of hospital stay for Group
M was 8.59 days (range: 4e15 days) and 8.39 days (range:
4e15 days) for Group S. The average hospitalization cost
was 3,076.4 USD (range: 713.8e5,693.2 USD) for Group M
and 3,261.3 USD (range: 806.4e5,567.1 USD) for Group S.
There were no statistically significant differences in
length of hospital stay and hospitalization cost between
the two groups (pZ 0.265 and pZ 0.649). In addition,
whether with pre-existing medical conditions or not, the
resource utilization of the population sample was not
Table 3 Resource utilization of the population sample.
All patients (nZ 97) Group M (nZ 46) Group S (nZ 51)
Operation time (h; range) 3.62 1.31 (1.33e7.67) 2.88 0.90 (1.33e5.33) 4.31 1.25* (2.50e7.67)
Length of stay (d; range) 8.48 4.44 (4e15) 8.59 5.69 (4e15) 8.39 2.93 (4e15)
Hospitalization cost
(USD; range)
3,173.7 860.5
(713.8e5,693.2)
3,076.4 787.0
(713.8e5,693.2)
3,261.3 920.8
(806.4e5,567.1)
Hospitalization cost was adjusted using the 2009e2010 average currency (USD/NTDZ1/31.56) published by Central Bank of the Republic
of China. *Indicates significant difference between Group M and Group S (p< 0.0001).
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log-linear regression model for resource utilization
revealed that patients in Group S were associated with
43% longer operation time (p< 0.0001; adjusted R2: 0.319)
when comparing that of patients in the Group M after
controlling for the observed covariates.Discussion
ACDF was first described by Smith et al in 1958 [6], and until
recently, some western studies had revealed that it takes
about 14,300e23,400 USD and 1e3 days of hospital stay for
patients undergoing ACDF procedures [3,7]. A more recent
study using the National Inpatient Sample of Canada
demonstrated a much higher cost for the surgery, which
was between 36,835 to 57,469 USD [8]. However, local data
for Taiwanese population are scanty. To the best of our
knowledge, this is the first local study in the literature to
examine the issue of both safety and resource utilization in
patients undergoing ACDF.
The incidence of potential common complications
associated with cervical spine surgery ranges from 2% to
70% [4]. Recurrent nerve palsy, respiratory insufficiency,
epidural hematoma, quadriplegia, and pharyngeal injury
occurred occasionally, with incidences ranging from 0.2%
to 1.1%. However, death was infrequently seen [3,9,10].
Higher complication rates associated with level 3 or higher
cervical surgery was noted in some studies [11]. We
therefore further classified the population sample into
two groups: patients with level 1 or 2 disease (Group M)
and those with level 3 or 4 disease (Group S), to draw
more valid conclusions regarding disease severity. The
initial descriptive analyses demonstrated that the two
groups were clinically homogeneous, except that patients
in Group S were older. Spondylosis refers to age-related
degenerative changes in the spinal column [12], there-
fore, it was reasonable to presume that the older pop-
ulation would develop more severe disease. However,
a wide age distribution was observed in our study, leading
to the interesting finding that DCS developed in younger
patients in Taiwan when compared to western or Japanese
studies [13,14]. Large studies are warranted to clarify the
causation of such a difference. The present study
described a complication rate of 1.0% for patients
undergoing multilevel ACDF. This rate was not higher than
those reported in the studies mentioned above. Patients
with level 3 or 4 disease in our study were expected
to have a higher rate of complications than those withlevel 1 or 2 disease. However, only one complication
occurred in the patients with level 3 or 4 disease,
which did not differ significantly from those with level 1 or
2 disease.
This study assumed that disease severity would affect
the risk of complications and resource utilization. Resource
utilization of length of hospital stay or hospitalization cost
was not significantly higher among patients with level 3 or 4
disease compared with level 1 or 2 disease. Instead, the
results of a log-linear regression model for resource utili-
zation revealed that patients with level 3 or 4 disease was
associated with 43% longer operation time when comparing
with patients with level 1 or 2 disease, after controlling for
the observed covariates. Many studies have concluded that
age and comorbidity are associated with the need for
critical care and prolonged hospitalization, which would
reflect higher hospitalization costs [15e17]. However, our
study results fail to verify this conclusion, partly because
operations for various levels of disease are reimbursed with
the same payment [e.g., operation fee is reimbursed at the
same rate (485.59 USD per ACDF) regardless of whether the
procedure is for a single-level or multilevel disease) by the
NHI authority in Taiwan. Fusion material is not yet reim-
bursed comprehensively by the NHI, and so patients must
pay for it themselves or wait until payment permission is
obtained. To avoid the cost bias of patient-paid, high-tech
prostheses, we therefore decided to use hospital inpatient
(NHI) reimbursement data for comparison of hospitalization
costs. A prospective, randomized controlled study in a more
carefully selected population sample is needed to give
a definitive clarification.
Limitations of the present study included a lack of
prospective randomized design, the small sample size, and
limited samples obtained from a single department
(neurosurgery) in our institution. A large, prospective
randomized study is warranted to determine factors
affecting the safety and resource utilization of patients
undergoing ACDF.
In conclusion, neurosurgical multilevel ACDF procedures
are safe. Among patients with level 3 or 4 disease, compared
with patients with level 1 or 2 disease, there was no higher
rate of complications, or no higher resource utilization of
length of hospital stay or hospitalization cost. However,
resource utilization of operation time was significantly
higher in this group of patients. These results demonstrate
the impact of disease severity on the incidence of compli-
cations and outcome differences. When surgery is consid-
ered appropriate for patients withmultilevel diseases, these
data suggest that ACDF should be the operation of choice.
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